Hemp and MJ are both forms of Cannabis sativa that are differentiated by their levels of THC.  The razor thin margin that separates legal commodity from illicit narcotic has been an unending source of risk for hemp farmers.  

The science of cannabinoids is rapidly evolving, with GW Pharma’s Epidiolex representing the pinnacle achievement of mainstream pharma, and a seemingly unsurmountable conflict between an approved drug and the vastness of cannabinoids.   The fastest growing segment in hemp derived cannabinoids is without a doubt ∆8-THC, despite increasing legislative pressure around the country.  

‘∆8’ serves a generic moniker representing a bewildering range of THC analogs, like ∆10, THC-O, or THCP.  States have taken varied approaches to ∆8, partly depending on whether they have legalized MJ.  Unregulated ∆8 – or other novel molecules – maintain an unfair advantage over highly regulated MJ.  None of it has been…